Prospects in the management of tear-deficiency states.
D000111:Acetylcysteine / Q000627:therapeutic use; D001762:Blepharitis / Q000150:complications; D003231:Conjunctivitis / Q000150:complications; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D013666:Tears / Q000378:metabolism; D014985:Xerophthalmia / Q000209:etiology / Q000601:surgery / Q000628:therapy*
D000111:Acetylcysteine